Clinical Trials at UI Healthcare Mission Cancer and Blood - Pella
As of July 2026, 14 paid clinical trials are recruiting at UI Healthcare Mission Cancer and Blood - Pella in Pella, Iowa. Active studies at this site cover conditions such as Myelodysplastic Syndrome, Acute Myeloid Leukemia and Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
14 clinical trials at UI Healthcare Mission Cancer and Blood - Pella
·Clear filters·Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
E-Mindfulness Approaches for Living After Breast Cancer
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Common conditions studied in Pella
- Myelodysplastic Syndrome (2 active studies)
- Acute Myeloid Leukemia (1 active study)
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm (1 active study)
- Acute Myeloid Leukemia Post Cytotoxic Therapy (1 active study)
- Acute Myeloid Leukemia, Myelodysplasia-Related (1 active study)
- Advanced Esophageal Adenocarcinoma (1 active study)
Leading research sponsors in Pella
- Alliance for Clinical Trials in Oncology
- National Cancer Institute (NCI)
- Canadian Cancer Trials Group
- Children's Oncology Group
- ECOG-ACRIN Cancer Research Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Pella?
There are approximately 14 recruiting clinical trials in Pella, Iowa listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Pella pay participants?
Most recruiting trials in Pella compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Pella?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Pella?
The most common conditions under active study in Pella include Myelodysplastic Syndrome (2), Acute Myeloid Leukemia (1), Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm (1), Acute Myeloid Leukemia Post Cytotoxic Therapy (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Pella?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Pella on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Pella?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Pella?
Recruiting research sites in Pella include UI Healthcare Mission Cancer and Blood - Pella, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Pella right now?
The largest active categories in Pella are Cancer & tumors (10), Mental health & behavior (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.